HomeForex MarketInsider TradingLigand Pharmaceuticals (NASDAQ:LGND) Reaches New 52-Week High Following Analyst Upgrade Ligand Pharmaceuticals (NASDAQ:LGND) Reaches New 52-Week High Following Analyst Upgrade August 31, 2025by Trade r edarT [ad_1] Ligand Pharmaceuticals (NASDAQ:LGND) Sets New 1-Year High After Analyst Upgrade [ad_2] Source link
Bouvel Investment Partners LLC Acquires New Stake in Broadcom Inc. $AVGO [ad_1] Bouvel Investment Partners LLC purchased a new position in shares of Broadcom Inc. (NASDAQ:AVGO – Free Report) during the…
Marshall & Sullivan Inc. WA Sells 917 Shares of Eli Lilly and Company $LLY [ad_1] Marshall & Sullivan Inc. WA decreased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 11.3%…
IDACORP (NYSE:IDA) Hits New 1-Year High – What's Next? [ad_1] IDACORP (NYSE:IDA) Hits New 12-Month High – Here’s Why [ad_2] Source link